U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953518) titled 'An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines' on April 16.
Brief Summary: This open-label pilot study includes adults aged 45 to 79 residing in the United States. The study will last 7 days. Participants will provide blood samples via an at-home finger-prick kit at baseline and day 7 and complete electronic surveys on health indicators at baseline, and days 3 and 7. All procedures are conducted remotely, with no in-person visits, to collect real-world evidence.
Study Start Date: May 12
Study Type: INTERVENTIONAL
Condition:
Inflammation
Intervention:
DIETARY_...